Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose corticosteroid injection therapy for knee arthritis
2009-018187-10Phase 4Active
- Sponsor
- Ziekenhuisgroep Twente
- Start
- Jan 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of triamcinolone acetonide in arthritis, rheumatoid arthritis (RA) and Chronic Systemic Inflammatory Arthritis (2 arms), sponsored by Ziekenhuisgroep Twente. Primary endpoints: Relief of symptoms by patient-assessed Likert scale, Number of responding patients and 1 more. Started Jan 2010; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
arthritisrheumatoid arthritis (RA)Chronic Systemic Inflammatory Arthritis
Beyond the preview
Go deeper on 2009-018187-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018187-10.